Regel Therapeutics Awarded $1 Million from HS Chau Women in Enterprising Science Program at the Innovative Genomics Institute to Continue Developing Its Gene Modulation Technology
/PRNewswire/ -- Regel Therapeutics, a next generation gene therapy company utilizing proprietary technology to modulate gene expression, today announced that...
United States United Kingdom Solina Chau Hoi Shuen Emmanuelle Charpentier Jennifer Doudna Steve Ruchefsky
Source: prnewswire.com